Mandatory Provident Fund

First Foundation Inc. Announces Senior Management Appointments

Retrieved on: 
Monday, November 21, 2022
Consulting, Banking, Professional Services, Finance, Trust, Certified Public Accountant, Senior, The Ted Noffs Foundation Inc, Charles Djou, Interim, Insurance, Mandatory Provident Fund, Growth, First Things First Foundation, Controller, Bank, Knowledge, Financial services, Management

First Foundation Inc. (NASDAQ: FFWM), a financial services company with two wholly-owned operating subsidiaries, First Foundation Advisors and First Foundation Bank, today announced that Chief Executive Officer, Scott F. Kavanaugh, has been named President of First Foundation Inc. and First Foundation Bank, effective immediately.

Key Points: 
  • First Foundation Inc. (NASDAQ: FFWM), a financial services company with two wholly-owned operating subsidiaries, First Foundation Advisors and First Foundation Bank, today announced that Chief Executive Officer, Scott F. Kavanaugh, has been named President of First Foundation Inc. and First Foundation Bank, effective immediately.
  • Amy Djou, First Foundation Banks Chief Accounting Officer, will assume the position of Interim Chief Financial Officer of First Foundation Inc. and First Foundation Bank while First Foundation conducts a comprehensive search for a permanent replacement.
  • Kavanaugh has served as CEO of First Foundation Inc. and First Foundation Bank since 2009.
  • First Foundation Inc. (NASDAQ: FFWM) and its subsidiaries offer personal banking, business banking, and private wealth management services, including investment, trust, insurance, and philanthropy services.

Approval by Mandatory Provident Fund Schemes Authority (“MPFA”) of ICBC CSOP FTSE Chinese Government and Policy Bank Bond Index ETF as approved Index-Tracking Collective Investment Schemes ("ITCIS")

Retrieved on: 
Tuesday, June 28, 2022
Banking, Professional Services, Finance, USD, HK, Legislative council, Securities and Futures Commission, Ministry, Industry, Bank of China, Agricultural Development Bank of China, Exim Bank, Ministry of Finance of the People's Republic of China, RMB, ETF, Risk, Investment, Security (finance), Mandatory Provident Fund, MPF, Qualification, Policy, Prospectus, Leadership, Government, ICBC, Agricultural Development Bank, CSOP, Bank, PRC

CSOP Asset Management Limited (CSOP) is glad to announce that ICBC CSOP FTSE Chinese Government and Policy Bank Bond Index ETF (ticker: 3199.

Key Points: 
  • CSOP Asset Management Limited (CSOP) is glad to announce that ICBC CSOP FTSE Chinese Government and Policy Bank Bond Index ETF (ticker: 3199.
  • HK) was admitted to Index-Tracking Collective Investment Schemes ("ITCIS") as the first Chinese government bond ETF approved by Mandatory Provident Fund Schemes Authority (MPFA) on 23 June 2022.
  • As of April 2022, foreign institutions hold more than RMB 3.7 trillion (over USD 580 billion) of onshore Chinese bonds6.
  • As the leading Chinese government bond ETF issuer in the region, CSOP manages the largest Chinese government bond ETFs in Hong Kong and Singapore respectively, bridging China onshore government bond market with investors in the region.

Tranquis Therapeutics Strengthens Leadership Team with Additions of Janet Hurt, MPH, as SVP of Clinical Evidence Generation and Faisal Shawwa, MBA, as SVP of Finance

Retrieved on: 
Wednesday, December 1, 2021
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Infectious Diseases, Clinical Trials, Patient, Department of Finance and Administration, Neurodegeneration, Catalysis, BS, Monocyte, MD, Mandatory Provident Fund, MBA, Stanford University, Amgen, COO, Onyx, Business, MPH, Record, San Jose State University, Research, Administration, Accounting, Bavarian Nordic, Therapy, CNS, Market for corporate control, Growth, Management, Pharmaceutical industry

Mr. Shawwa and Ms. Hurt will be members of Tranquis Executive Leadership Team.

Key Points: 
  • Mr. Shawwa and Ms. Hurt will be members of Tranquis Executive Leadership Team.
  • In 2022, we anticipate building on this momentum, making significant clinical progress with TQS-168, advancing our pipeline and expanding our discovery platform.
  • Janet Hurt brings 30 years of early and late-stage clinical development expertise to Tranquis.
  • Prior to Jasper, Janet has led clinical operations, clinical data management and clinical outsourcing at several biopharmaceutical companies including Denali Therapeutics, Onyx, Bavarian Nordic, XenoPort, and Amgen.